Table 3.
Procedure | Total (N = 2494) |
Region |
Practice setting |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Africa (n = 209) |
E/SE Asia (n = 441) |
Europe (n = 1074) |
North America (n = 186) |
South America (n = 198) |
W/SW Asia (n = 386) |
Academic (n = 1161) |
Private (n = 719) |
Public (n = 614) |
||
Other benign conditionsb | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
BPH surgery | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Stone management | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Radical prostatectomy (localised PCa) | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
RPLND | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Radical/partial nephrectomy | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 |
Nephroureterectomy | 7 | 9 | 9 | 8 | 7 | 7 | 8 | 8 | 7 | 7 |
Radical cystectomy | 8 | 8 | 8 | 9 | 8 | 8 | 6 | 9 | 8 | 8 |
TUR of bladder tumour | 9 | 10 | 10 | 7 | 9 | 9 | 10 | 7 | 10 | 9 |
Radical orchidectomy/penectomy | 10 | 7 | 7 | 10 | 10 | 10 | 9 | 10 | 9 | 10 |
BPH = benign prostatic hyperplasia; COVID-19 = coronavirus 2019; E/SE = East/Southeast; PCa = prostate cancer; RPLND = retroperitoneal lymph node dissection; TUR = transurethral resection; W/SW = West/Southwest.
Rank order from 1 to 10: 1 = lowest priority; 10 = highest priority.
varicocele, hydrocele, circumcision, TVTs, etc.